Colgate Palmolive (CL) Other Accumulated Expenses (2009 - 2026)

Colgate Palmolive's Other Accumulated Expenses history runs 18 years deep, the most recent figure standing at $3.4 billion for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 16.88% year-over-year to $3.4 billion in Q1 2026; TTM through Mar 2026 was $3.4 billion, a 16.88% increase from a year earlier, with the FY2025 full-year figure at $3.3 billion, up 12.9% from the prior year.
• Other Accumulated Expenses improved to $3.4 billion in Q1 2026 per CL's latest filing, from $3.3 billion in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $3.4 billion in Q1 2026 and bottomed at $2.1 billion in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $2.7 billion (2023), against an average of $2.8 billion.
• Across the five-year window, Other Accumulated Expenses declined 2.66% in 2022 and gained 21.62% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $2.1 billion in 2022, then grew by 12.6% to $2.4 billion in 2023, then grew by 21.62% to $2.9 billion in 2024, then increased by 12.9% to $3.3 billion in 2025, then increased by 2.88% to $3.4 billion in 2026.
• Per Business Quant, the three latest CL Other Accumulated Expenses figures stand at $3.4 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.2 billion (Q3 2025).